Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Breast Cancer (Dove Medical Press)|June 22, 2018
Mechanism of metastasis suppression by luteolin in breast cancerMatthew T Cook
Behavior Research Methods|June 10, 2017
AGSuite: Software to conduct feature analysis of artificial grammar learning performanceMatthew T Cook, Chrissy M Chubala, Randall K Jamieson
Breast Cancer (Dove Medical Press)|January 19, 2017
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cellsMatthew T Cook, Yayun Liang, Cynthia Besch-Williford, et al.
Behavior Research Methods|June 27, 2019
The Semantic Librarian: A search engine built from vector-space models of semanticsHarinder Aujla, Matthew J C Crump, Matthew T Cook, et al.
American Journal of Physiology. Cell Physiology|March 10, 2012
Functional Cftr in crypt epithelium of organotypic enteroid cultures from murine small intestineJinghua Liu, Nancy M Walker, Matthew T Cook, et al.
Breast Cancer (Dove Medical Press)|June 6, 2017
Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitroSandy Goyette, Yayun Liang, Benford Mafuvadze, et al.
Springerplus|August 28, 2015
Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenograftsMatthew T Cook, Yayun Liang, Cynthia Besch-Williford, et al.
Breast Cancer (Dove Medical Press)|September 20, 2019
APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude miceYayun Liang, Cynthia Besch-Williford, Matthew T Cook, et al.
Oncology Reports|January 1, 2016
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley ratsMatthew T Cook, Benford Mafuvadze, Cynthia Besch-Williford, et al.
Breast Cancer Research and Treatment|June 1, 2014
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071Yayun Liang, Cynthia Besch-Williford, Johannes D Aebi, et al.
Pageof 2